News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...
In order to better prevent blood clots, the drugs clopidogrel or prasugrel can be prescribed to patients with acute ischaemia of the heart muscle, in addition to acetylsalicylic acid (ASA). The German ...
The optimal timing of clopidogrel dosing and administration in the setting of percutaneous coronary intervention (PCI) remains an intense area of investigation. A series of studies -- Antiplatelet ...
In a recent randomized study, Gurbel and colleagues have examined the effect of clopidogrel dosing on the incidence of nonresponsiveness and high post-treatment platelet aggregation. In comparison ...
Antiplatelet therapy with Plavix ® (clopidogrel bisulfate) and aspirin reduces major cardiovascular events in ACS patients during and after coronary angioplasty, also referred to as percutaneous ...
Patients with high-risk features undergoing elective PCI and treated with the more-potent antiplatelet agent ticagrelor (Brilinta; AstraZeneca) instead of clopidogrel fared no better with respect to ...
Antiplatelet drug therapy has become one of the cornerstones of treatment for patients with cardiovascular disease. Large clinical trials have shown that antiplatelet medications have important ...
Clopidogrel is a generic prescription oral tablet that’s used to lower the risk of stroke and heart attack in certain adults. The drug is also available as the brand-name drug Plavix. It’s not known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results